BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 2215269)

  • 1. Clinical use of oestrogens and progestogens.
    Lauritzen C
    Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of estrogens and progestogens.
    L'Hermite M
    Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraception for the transitional years of women older than 40 years of age.
    Upton GV; Corbin A
    Clin Obstet Gynecol; 1992 Dec; 35(4):855-64. PubMed ID: 1451368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
    Dorflinger LJ
    Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oestrogens and progestogens.
    Kuhl H
    Maturitas; 1990 Sep; 12(3):171-97. PubMed ID: 2170822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogen potency in oral contraceptive pills.
    Gillmer MD
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1048-52. PubMed ID: 3118717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.